Reply: regarding the effect of dabigatran plasma concentrations.
暂无分享，去创建一个
[1] S. Yusuf,et al. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). , 2014, Journal of the American College of Cardiology.
[2] Marsha E Reichman,et al. Dabigatran and postmarketing reports of bleeding. , 2013, The New England journal of medicine.
[3] E. Unger,et al. Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran. , 2011, The New England journal of medicine.